Incidence of the involvement of the cardiovascular system in HIV infection

Area of Science:

• Cardiology
• Infectious Diseases
• Public Health

Background:

• Cardiovascular complications are a growing concern in individuals with human immunodeficiency virus (HIV).
• Factors contributing to cardiac issues include chronic viral infection, co-infections, antiretroviral drug therapies, and immunosuppression.
• The spectrum of cardiac disease in HIV encompasses cardiomyopathy, left ventricular hypertrophy, myocarditis, pericardial effusion, endocarditis, and cardiac malignancies.

Purpose of the Study:

• To discuss the epidemiology of cardiac complications in HIV-infected individuals.
• To highlight the anticipated increase in cardiac complications over the next decade.
• To emphasize the importance of understanding HIV-related cardiac disease for patient management and therapeutic evaluation.

Main Methods:

• This is a discussion and review of existing knowledge on the epidemiology of cardiac complications in HIV.
• Literature review on the impact of HIV, co-infections, and treatments on cardiovascular health.
• Analysis of factors influencing the development and progression of cardiac disease in the context of HIV.

Main Results:

• An increasing prevalence of cardiac complications is projected among HIV-infected populations.
• HIV, its treatments, and associated conditions significantly impact cardiovascular health.
• Specific cardiac conditions such as cardiomyopathy and myocarditis are frequently observed.

Conclusions:

• Early recognition and monitoring of cardiac complications in HIV are crucial.
• Understanding the pathophysiology and clinical course of HIV-related heart disease is essential for effective management.
• Establishing a baseline understanding will aid in assessing the cardiovascular effects of novel treatments, including highly active antiretroviral therapy (HAART).